Alnylam is lower after releasing topline data for lumasiran from kidney disease trial
July 29 2021 - 8:16AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Alnylam Pharmaceuticals (NASDAQ:ALNY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alnylam Pharmaceuticals (NASDAQ:ALNY)
Historical Stock Chart
From Apr 2023 to Apr 2024